期刊文献+

p21 ras、p53、c-myc、PCNA在子宫内膜腺癌中的表达 被引量:8

Expression of p21 ras, p53, c myc, and PCNA in endometral adenocarcinoma
下载PDF
导出
摘要 目的:探讨癌基因与子宫内膜腺癌的关系。方法:应用免疫组化LSAB法对33例原发性子宫内膜腺癌进行p21ras,p53,c-myc和PCNA的检测。结果:p53表达为78.8%,p21ras表达为51.5%,c-myc表达为81.8%,PCNA表达为97%。均明显高于正常增殖期子宫内膜(P<0.05)。p21ras和p53在正常子宫内膜无表达,因此比c-myc在子宫内膜腺癌的表达更特异。本研究显示p53与子宫内膜腺癌的病理分级有关(P<0.05),p21ras与转移有关(P<0.05),在子宫内膜腺癌中,p53的表达与p21ras的表达之间呈显著相关(P<0.01),本研究显示3种癌基因(p21ras,p53和c-myc)共同表达占48.5%。结论:p53和p21ras共同与子宫内膜腺癌的发生和发展有关。子宫内膜腺癌是多种基因作用的结果。 Purpose To explore the relation between oncogene and endometral adenocarcinoma; Methods The expressions of p21 ras, p53, c myc and PCNA were studied in 33 case of endometral adenocarcinoma by LSAB immunohistochemical technique; Results The results showed that the positivity rates of p53, pzlras, c myc and PCNA were 78 8%, 51 5%,81 8% and 97% respectively. The expressions of p21 ras, p53, c myc and PCNA in endometral adenocarcinoma were significantly higher than those in normal endometrum ( P< 0 05). The p21 ras expression was associated with metastasis ( P< 0 05). The p53 expression was correlated with histological grade ( P< 0 05). There was significant correlation between the expression of p53 and that of p21 ras in endometral adenocarcinoma ( P< 0 01). The coexpressions of p21 ras, p53 and c myc were 48 5%; Conclusions p53 cooperates with p21 ras in the pathogenisis and development of endometral adenocarcinoma. Endometral adenocarcinoma is the result of the cooperation of many oncogenes.
作者 高昕 吴小青
出处 《临床与实验病理学杂志》 CAS CSCD 1997年第2期130-132,共3页 Chinese Journal of Clinical and Experimental Pathology
关键词 子宫内膜腺癌 p21-ras P53 C-MYC PCNA endometral adenocarcinoma p21 ras p53 PCNA c myc immunohistochemistry
  • 相关文献

同被引文献40

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2刘振声,丁华野.喉癌ras癌基因产物P21免疫组化检测及其临床意义[J].中华耳鼻咽喉科杂志,1993,28(5):295-296. 被引量:2
  • 3邓志鸿.PCNA在肿瘤病理学上的应用[J].临床与实验病理学杂志,1994,10(4):331-333. 被引量:37
  • 4曹斌融 张惜阴.子宫内膜癌.临床妇科肿瘤学[M].上海:上海医科大学出版社,1993.126-142.
  • 5乔云波 许俐.子宫内膜癌基因研究进展[J].国外医学:肿瘤学分册,1998,:153-154.
  • 6TSUTSUI S,OHNO S,MURAKAMI S,et al.Prognosistic value of CerbB-2 expression in breast caner[J].Surg Oncol,2002,79(4):216-231.
  • 7Bens EM,FoeKens JA,Van Stanveren IL,et al.Oncogene am-plification and prognosis in breast cancer relationship with systemic treatment-gene.1995,159:11-18.
  • 8Miller C, Koeffler HP. P53 mutations in human cancers.Leukemia, 1993 ,7( Suppl 2) :S18.
  • 9Umar A, Kukel. DNA-replication fidelity, mismatch repair and genone instability in cancer cells. Eur J Biochem, 1996;238:297.
  • 10Brintnall T. Mierosatellite instabihty-shifting concepts in tumorigenesis. Am J Pathol, 1995, 147:561.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部